Curcumin and chronic kidney disease (CKD): major mode of action through stimulating endogenous intestinal alkaline phosphatase (Q38283016)

2 July 2019

4 references

9 September 2019

28 September 2019

7 November 2019

29 May 2020

Curcumin and chronic kidney disease (CKD): major mode of action through stimulating endogenous intestinal alkaline phosphatase (English)

1 reference

2 July 2019

chronic renal insufficiency

0 references

1 reference

9 September 2019

3 references

9 September 2019

28 September 2019

7 November 2019

1 reference

28 September 2019

1 reference

7 November 2019

Siddhartha S Ghosh

1

1 reference

2 July 2019

Todd W B Gehr

series ordinal

2

1 reference

2 July 2019

Shobha Ghosh

series ordinal

3

1 reference

2 July 2019

language of work or name

English

0 references

publication date

2 December 2014

4 references

2 July 2019

9 September 2019

28 September 2019

7 November 2019

4 references

2 July 2019

9 September 2019

28 September 2019

7 November 2019

19

1 reference

2 July 2019

issue

12

1 reference

2 July 2019

page(s)

20139-20156

1 reference

2 July 2019

Creative Commons Attribution

copyright license

3 references

9 September 2019

28 September 2019

7 November 2019

0 references

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Chronic kidney disease: global dimension and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Therapeutic roles of curcumin: lessons learned from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Curcumin: from ancient medicine to current clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Curcumin, a component of golden spice: from bedside to bench and back

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Molecular mechanisms of curcumin action: gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Cyclooxygenase-2 and kidney failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Curcumin and enalapril ameliorate renal failure by antagonizing inflammation in 5/6 nephrectomized rats: role of phospholipase and cyclooxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

5-Lipoxygenase-mediated mitochondrial damage and apoptosis of mononuclear cells in ESRD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

5-lipoxygenase: regulation and possible involvement in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Inflammatory and atherosclerotic interactions in the depleted uremic patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Consent for research with biological samples: one-time general consent versus a gift model

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

The use of an anti-inflammatory supplement in patients with chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Effect of redox modulating NRF2 activators on chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Oxidative stress, anti-oxidant therapies and chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Growth factor pathways in proliferative glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Curcumin prevents cardiac remodeling secondary to chronic renal failure through deactivation of hypertrophic signaling in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Regulation of PPARgamma function by TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Anti-inflammatory interventions of NF-kappaB signaling: potential applications and risks

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Crosstalk in NF-κB signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Transcription factor-kappa B (NF-kappa B) and renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Nrf2-keap1 system versus NF-κB: the good and the evil in chronic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Chronic inhibition of nuclear factor-kappaB attenuates renal injury in the 5/6 renal ablation model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Atherosclerosis in chronic kidney disease: the role of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Hypertension and kidney disease: what do the data really show?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Current issues in the management and monitoring of hypertension in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Curcumin reverses glomerular hemodynamic alterations and oxidant stress in 5/6 nephrectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

How does proteinuria cause progressive renal damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

A bench to bedside view of uremic toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

New insights in uremic toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Normal and pathologic concentrations of uremic toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Innate and adaptive inflammation as a therapeutic target in vascular disease: the emerging role of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Curcumin inhibits monocyte chemoattractant protein-1 expression and enhances cholesterol efflux by suppressing the c-Jun N-terminal kinase pathway in macrophage

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Oral supplementation with non-absorbable antibiotics or curcumin attenuates western diet-induced atherosclerosis and glucose intolerance in LDLR-/- mice--role of intestinal permeability and macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Endotoxin-binding affinity of sevelamer: a potential novel anti-inflammatory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Bioavailability of curcumin: problems and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Pharmacokinetics and pharmacodynamics of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Curcumin uptake and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

The gut microbiome, kidney disease, and targeted interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

The uremic toxin indoxyl sulphate enhances macrophage response to LPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Curcumin inhibits the increase of glutamate, hydroxyl radicals and PGE2 in the hypothalamus and reduces fever during LPS-induced systemic inflammation in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Role of bacterial endotoxin in chronic heart failure: the gut of the matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

The tight junction in inflammatory disease: communication breakdown

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Removal of phosphate from lipid A as a strategy to detoxify lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Intestinal alkaline phosphatase: novel functions and protective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Study on the antibiotic activity of microcapsule curcumin against foodborne pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Impact of chronic kidney disease on carotid plaque vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191220139

Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes

21 January 2018

1 reference

12 December 2020

Subtotal nephrectomy stimulates cyclooxygenase 2 expression and prostacyclin synthesis in the rat remnant kidney

1 reference

12 December 2020

The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats

1 reference

12 December 2020

Effect of Febuxostat on the Progression of Renal Disease in 5/6 Nephrectomy Rats with and without Hyperuricemia

1 reference

12 December 2020

Impact of renal function on coronary plaque composition

1 reference

12 December 2020

Nutritional compounds influence tissue factor expression and inflammation of chronic kidney disease patients in vitro

1 reference

12 December 2020

Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats

1 reference

12 December 2020

Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism

1 reference

12 December 2020

Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline

1 reference

12 December 2020

Curcumin induces Nrf2 nuclear translocation and prevents glomerular hypertension, hyperfiltration, oxidant stress, and the decrease in antioxidant enzymes in 5/6 nephrectomized rats

1 reference

12 December 2020

Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway

1 reference

12 December 2020

Metabolic syndrome and chronic kidney disease

1 reference

12 December 2020

Curcumin alleviates immune-complex-mediated glomerulonephritis in factor-H-deficient mice

1 reference

12 December 2020

The Nrf2 pathway in the progression of renal disease

1 reference

12 December 2020

The global issue of kidney disease

1 reference

12 December 2020

Progression of renal injury toward interstitial inflammation and glomerular sclerosis is dependent on abnormal protein filtration

1 reference

12 December 2020

10.3390/MOLECULES191220139

Identifiers

DOI

1 reference

2 July 2019

PMCID

6271001

1 reference

2 July 2019

PubMed ID

25474287

1 reference

2 July 2019